Fortress Biotech (FBIO) Other Accumulated Expenses (2016 - 2025)
Fortress Biotech has reported Other Accumulated Expenses over the past 9 years, most recently at $135000.0 for Q4 2025.
- Quarterly results put Other Accumulated Expenses at $135000.0 for Q4 2025, down 91.02% from a year ago — trailing twelve months through Dec 2025 was $135000.0 (down 91.02% YoY), and the annual figure for FY2025 was $135000.0, down 91.02%.
- Other Accumulated Expenses for Q4 2025 was $135000.0 at Fortress Biotech, roughly flat from $135000.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for FBIO hit a ceiling of $2.1 million in Q1 2025 and a floor of $135000.0 in Q3 2025.
- Median Other Accumulated Expenses over the past 4 years was $996000.0 (2022), compared with a mean of $873307.7.
- Peak annual rise in Other Accumulated Expenses hit 1213.5% in 2025, while the deepest fall reached 91.02% in 2025.
- Fortress Biotech's Other Accumulated Expenses stood at $996000.0 in 2022, then plummeted by 83.63% to $163000.0 in 2023, then soared by 822.7% to $1.5 million in 2024, then plummeted by 91.02% to $135000.0 in 2025.
- The last three reported values for Other Accumulated Expenses were $135000.0 (Q4 2025), $135000.0 (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.